![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, November 03, 2019 11:31:54 AM
The company will probably be happy to keep this listed over a buck. The individual investor is a wonderful source of revenue, they can milk this approval for quite some time too if they want. For the sake of the people who need the treatment and the investors who made it possible, I hope for real fast track momentum with the SP and the FDA.
All posts are my opinion and not a buy or sell stock recommendation.
I do not work for any financial firm nor am I part of a group of traders.
Recent SESN News
- Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights • PR Newswire (US) • 08/10/2023 11:30:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM